Treatment hsct. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Antilymphocyte Serum T-Lymphocytes Thymus Gland Philadelphia Chromosome Hematopoietic Stem Cells Killer Cells, Natural CD8-Positive T-Lymphocytes T-Lymphocytes, Regulatory T-Lymphocytes, Cytotoxic Fetal Blood Gastrointestinal Tract CD4-Positive T-Lymphocytes T-Lymphocyte Subsets B-Lymphocytes

Organisms8

Transplantation Chimera Cytomegalovirus BK Virus Aspergillus Mice, Inbred C57BL Herpesvirus 4, Human Adenoviridae Mice, Inbred BALB C

Diseases63

Graft vs Host Disease Hematologic Neoplasms Leukemia Hematologic Diseases Mycoses Hepatic Veno-Occlusive Disease Recurrence Cytomegalovirus Infections Aspergillosis Severe Combined Immunodeficiency Leukemia, Myeloid, Acute Lymphoproliferative Disorders Acute Disease Myelodysplastic Syndromes Lymphohistiocytosis, Hemophagocytic Bronchiolitis Obliterans Opportunistic Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Anemia, Aplastic Cystitis Stomatitis Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Roseolovirus Infections Mucositis Leukemia, Myeloid Hemoglobinopathies Autoimmune Diseases Iron Overload Neutropenia Polyomavirus Infections Adenovirus Infections, Human Epstein-Barr Virus Infections Lung Diseases, Fungal Adenoviridae Infections Multiple Myeloma Thalassemia Infection Philadelphia Chromosome Chronic Disease Syndrome Fever Lymphoma Multiple Organ Failure Lung Diseases Immunologic Deficiency Syndromes Pneumonia Fatigue Hemorrhage Postoperative Complications Viremia Respiratory Tract Infections Thrombocytopenia Scleroderma, Systemic Multiple Sclerosis Bacteremia Bacterial Infections Neuroblastoma Lymphoma, Non-Hodgkin Hodgkin Disease Neoplasm Recurrence, Local Disease Progression Disease Models, Animal

Chemicals and Drugs33

Myeloablative Agonists Busulfan Vidarabine Antilymphocyte Serum Immunosuppressive Agents HLA Antigens Cyclophosphamide Receptors, KIR Ganciclovir Antifungal Agents Antiviral Agents Minor Histocompatibility Antigens Melphalan Immunoglobulins, Intravenous Triazoles ABO Blood-Group System Cytarabine Antineoplastic Agents Pyrimidines Cyclosporine Antigens, CD34 Immunologic Factors Methotrexate Biological Markers Antibodies, Monoclonal Interferon-gamma Antibodies, Monoclonal, Murine-Derived Prednisone Protein Kinase Inhibitors Antigens, Viral DNA, Viral Anti-Bacterial Agents Antigens, CD

Analytical, Diagnostic and Therapeutic Techniques and Equipment75

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Transplantation, Autologous Treatment Outcome Retrospective Studies Histocompatibility Testing Whole-Body Irradiation Cord Blood Stem Cell Transplantation Survival Analysis Peripheral Blood Stem Cell Transplantation Donor Selection Bone Marrow Transplantation Stem Cell Transplantation Follow-Up Studies Transplantation Survival Rate Disease-Free Survival Risk Factors Remission Induction Enzyme Replacement Therapy Thermometry Lymphocyte Depletion Combined Modality Therapy Immunosuppression Prospective Studies Platelet Transfusion Cohort Studies Incidence Salvage Therapy Prognosis Organ Transplantation Transplantation, Isogeneic Kaplan-Meier Estimate Multivariate Analysis Drug Monitoring Flow Cytometry Antineoplastic Combined Chemotherapy Protocols Lymphocyte Transfusion Clinical Trials, Phase II as Topic Blood Transfusion, Autologous Viral Load Hematopoietic Stem Cell Mobilization Lymphocyte Count Immunotherapy, Adoptive Severity of Illness Index Immunotherapy Registries Fatal Outcome Case-Control Studies Statistics, Nonparametric Treatment Failure Immunophenotyping Feasibility Studies Proportional Hazards Models Risk Genetic Therapy Patient Selection Polymerase Chain Reaction Probability Risk Assessment Cell Count Reverse Transcriptase Polymerase Chain Reaction Reproducibility of Results Randomized Controlled Trials as Topic Disease Models, Animal Longitudinal Studies Data Collection Reoperation Double-Blind Method Lymphocyte Activation Tomography, X-Ray Computed Predictive Value of Tests Questionnaires Prevalence

Psychiatry and Psychology7

Siblings Adjustment Disorders Problem Solving Adaptation, Psychological Stress, Psychological Psychometrics Depression

Phenomena and Processes24

Graft vs Leukemia Effect Chimerism Histocompatibility Graft vs Tumor Effect Immunocompromised Host Time Factors Graft Survival Transplantation Immunology Virus Activation Philadelphia Chromosome Transplantation Tolerance Graft Rejection Viral Load Lymphocyte Count Hematopoiesis Risk Probability Cell Count Immunologic Memory Genotype Lymphocyte Activation Phenotype Cell Differentiation Dose-Response Relationship, Drug

Anthropology, Education, Sociology and Social Phenomena3

Siblings Quality of Life Social Support

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Fatal Outcome Data Collection Questionnaires Prevalence

Named Groups7

Tissue Donors Siblings Survivors Living Donors Infant, Newborn Blood Donors Caregivers

Health Care37

Treatment Outcome Retrospective Studies Survival Analysis Donor Selection Follow-Up Studies Survival Rate Disease-Free Survival Risk Factors Prospective Studies Cohort Studies Incidence Kaplan-Meier Estimate Multivariate Analysis Clinical Trials, Phase II as Topic Age Factors Severity of Illness Index Registries Fatal Outcome Case-Control Studies Statistics, Nonparametric Infection Control Treatment Failure Feasibility Studies Proportional Hazards Models Risk Patient Selection Caregivers Probability Risk Assessment Reproducibility of Results Randomized Controlled Trials as Topic Longitudinal Studies Data Collection Double-Blind Method Predictive Value of Tests Questionnaires Prevalence

Geographicals6

Europe Mediterranean Region Italy Brazil United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Graft vs Host Disease Transplantation Conditioning Hematologic Neoplasms Transplantation, Autologous Treatment Outcome Retrospective Studies Tissue Donors Graft vs Leukemia Effect Leukemia Myeloablative Agonists Chimerism Histocompatibility Hematologic Diseases Histocompatibility Testing Busulfan Transplantation Chimera Mycoses Whole-Body Irradiation Hepatic Veno-Occlusive Disease Vidarabine Recurrence Cytomegalovirus Infections Aspergillosis Cord Blood Stem Cell Transplantation Graft vs Tumor Effect Antilymphocyte Serum Survival Analysis Siblings Peripheral Blood Stem Cell Transplantation Donor Selection Severe Combined Immunodeficiency Leukemia, Myeloid, Acute Bone Marrow Transplantation Immunocompromised Host Lymphoproliferative Disorders Acute Disease Stem Cell Transplantation Myelodysplastic Syndromes Time Factors Europe Follow-Up Studies Lymphohistiocytosis, Hemophagocytic Bronchiolitis Obliterans Transplantation Survival Rate Immunosuppressive Agents HLA Antigens Opportunistic Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Graft Survival Disease-Free Survival Anemia, Aplastic Risk Factors Remission Induction Cytomegalovirus Cystitis Enzyme Replacement Therapy Thermometry Transplantation Immunology Lymphocyte Depletion T-Lymphocytes Stomatitis Combined Modality Therapy Immunosuppression Survivors Mediterranean Region Neoplasms Prospective Studies Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cyclophosphamide Roseolovirus Infections Receptors, KIR Ganciclovir Platelet Transfusion Antifungal Agents Cohort Studies Adjustment Disorders Mucositis BK Virus Leukemia, Myeloid Incidence Salvage Therapy Hemoglobinopathies Antiviral Agents Prognosis Minor Histocompatibility Antigens Organ Transplantation Autoimmune Diseases Iron Overload Neutropenia Polyomavirus Infections Virus Activation Transplantation, Isogeneic Adenovirus Infections, Human Epstein-Barr Virus Infections Living Donors Lung Diseases, Fungal Adenoviridae Infections

No FAQ available that match "treatment hsct"